Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals

4484 Congresses

10100+ Unique Records

Molecular Oncology

Title Abbreviation

Mol Oncol

Electronic ISSN

1878-0261

Therapeutic Area

Clinical Pharmacology, Genomics, Immunology, Medical Technology, Molecular Medicine, Nuclear Medicine, Oncology, Pathology

Readership

Biomedical Researchers, Cell Biologists, Clinical Pharmacologists, Clinicians, Endocrinologists, Epidemiologists, Health Scientists, Immunologists, Molecular Biologists, Nuclear Medicine Physicians, Oncologists, Pathologists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Physicians - Medicine, Radiation Oncologists, Scientists, Surgical Oncologists

Scope

Molecular Oncology is a monthly online-only Open Access journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research. The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients. Submissions that meet the high standards of the journal are sent for rigorous, single-blind peer review by experts in the field. Topics include, but are not limited to: Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response. Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems. Biomarkers: diagnosis, prognosis, stratification and efficacy. Cancer genetics, epigenetics, and genomic instability. Minimal residual disease, pre-malignant lesions. Cancer micro-environment. Molecular pathology. Tumour immunology. Translational research. Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment). Chemotherapy, radiotherapy and surgery. Clinical pharmacology. Clinical trials, integration of basic science into cancer clinical trials. Molecular epidemiology.

Sponsoring Association(s)

Federation of European Biochemical Societies (FEBS)

Publisher Name

John Wiley & Sons, Inc. - NJ

To see more details about Molecular Oncology, Subscribe Now!

Impact Factor JCR Categories/Rank Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us